drugset / Trial / NCT07469982
A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single-arm, multicenter, dose-escalation and dose-expansion, phase I study to the safety, tolerability, pharmacokinetics, and preliminary efficacy of SY-9453 in patients with advanced solid tumors.
Timeline
- Start
- 2026-03-12
- Primary completion
- 2027-02
- Completion
- 2029-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SY-9453 | Unknown | 5 mg | Oral |
| Subject | SY-9453 | Unknown | 80 mg | Oral |